JMJD4 Antikörper (AA 1-463)
-
- Target Alle JMJD4 Produkte
- JMJD4 (Jumonji Domain Containing 4 (JMJD4))
-
Bindungsspezifität
- AA 1-463
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser JMJD4 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- MRAGPEPQAL AGQKRGALRL LVPRLVLTVS APAEVRRRVL RPVLSWMDRE TRALADSHFR GLGVDVPGVG QAPGRVAFVS EPGAFSYADF VRGFLLPNLP CVFSSAFTQG WGSRRRWVTP AGRPDFDHLL RTYGDVVVPV ANCGVQEYNS NPKEHMTLRD YITYWKEYIQ AGYSSPRGCL YLKDWHLCRD FPVEDVFTLP VYFSSDWLNE FWDALDVDDY RFVYAGPAGS WSPFHADIFR SFSWSVNVCG RKKWLLFPPG QEEALRDRHG NLPYDVTSPA LCDTHLHPRN QLAGPPLEIT QEAGEMVFVP SGWHHQVHNL DDTISINHNW VNGFNLANMW RFLQQELCAV QEEVSEWRDS MPDWHHHCQV IMRSCSGINF EEFYHFLKVI AEKRLLVLRE AAAEDGAGLG FEQAAFDVGR ITEVLASLVA HPDFQRVDTS AFSPQPKELL QQLREAVDAA AAP
- Kreuzreaktivität
- Human, Maus, Ratte
- Produktmerkmale
- Polyclonal Antibodies
- Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-463 of human JMJD4 (NP_075383.2).
- Isotyp
- IgG
-
anti-Jumonji Domain Containing 4 (JMJD4) (AA 423-455), (C-Term) antibody
JMJD4 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB10802 unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (AA 1-30), (N-Term) antibodyJMJD4 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB10799 unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) antibodyJMJD4 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (C-Term) antibodyJMJD4 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (AA 72-121) antibodyJMJD4 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (C-Term) antibodyJMJD4 Reaktivität: Human, Maus, Ratte, Schwein, Hund, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (AA 1-30) antibodyJMJD4 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (N-Term) antibodyJMJD4 Reaktivität: Human, Ratte WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 4 (JMJD4) (C-Term) antibodyJMJD4 Reaktivität: Human, Maus WB, EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB,1:1000 - 1:5000
- Kommentare
-
HIGH QUALITY
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- JMJD4 (Jumonji Domain Containing 4 (JMJD4))
- Andere Bezeichnung
- JMJD4 (JMJD4 Produkte)
- Synonyme
- JMJD4 antikoerper, 6430559I23 antikoerper, RGD1307186 antikoerper, jumonji domain containing 4 antikoerper, jumonji domain containing 4 L homeolog antikoerper, JMJD4 antikoerper, jmjd4.L antikoerper, Jmjd4 antikoerper
- Hintergrund
- Catalyzes the 2-oxoglutarate and iron-dependent C4-lysyl hydroxylation of ETF1 at 'Lys-63' thereby promoting the translational termination efficiency of ETF1.,JMJD4,Epigenetics & Nuclear Signaling,JMJD4
- Molekulargewicht
- 50 kDa/52 kDa
- Gen-ID
- 65094
- UniProt
- Q9H9V9
-
